Evaluation of occult uterine leiomyosarcomas

Ginekol Pol. 2019;90(8):433-437. doi: 10.5603/GP.2019.0075.

Abstract

Objectives: To determine the frequency of occult uterine leiomyosarcomas following hysterectomies and myomectomiesperformed for benign reasons at our clinic and to draw comparisons with similar studies in the literature.

Material and methods: All hysterectomies and myomectomies that have been performed for benign reasons at our clinicbetween 2010 and 2017 were retrospectively examined via the hospital's information system and the patients that werefound to have leiomyosarcomas were analysed. The incidence of occult uterine leiomyosarcoma per 1000 surgeries at ourclinic was calculated using the Wilson score interval.

Results: A total of 6,173 hysterectomies were performed, and occult uterine leiomyosarcoma was identified in 5 patients. Theincidence of occult uterine leiomyosarcoma was calculated to be 0.08% (95% CI 0.03-0.018%). Only 1 of the 771 patientswho underwent myomectomy was identified with occult uterine leiomyosarcoma, making its incidence in myomectomy0.12% (95% CI 0.02-0.073%). When all the patients are considered, occult uterine leiomyosarcoma was identified in 6 of the6,944 patients, and the general incidence of occult uterine leiomyosarcoma was calculated as 0.08% (95% CI 0.03-0.018%).

Conclusions: In our study, the incidence of occult uterine sarcoma following myomectomy and hysterectomy was foundto be lower than that reported in the literature. The reason for this lower incidence includes not only genetic causes andracial differences but also preoperative imaging, endometrial and cervical sampling that is performed on every patient.

Keywords: hysterectomy; leiomyosarcoma; myoma; myomectomy.

MeSH terms

  • Adult
  • Female
  • Humans
  • Hysterectomy / adverse effects*
  • Incidence
  • Leiomyosarcoma / epidemiology*
  • Leiomyosarcoma / etiology*
  • Middle Aged
  • Retrospective Studies
  • Turkey / epidemiology
  • Uterine Myomectomy / adverse effects*
  • Uterine Neoplasms / epidemiology*
  • Uterine Neoplasms / etiology*